Billings Clinic
Especially For:

Clinical Trials

Title   Bladder Ca:C90601 Advanced Transitional Cell Carcinoma
Description   A Randomized, Double-Blind Phase III Trial comparing Gemcitabine, Cisplatin & Bevacizumab to Gemcitabine, Cisplatin & Placebo Pts w advanced Transitional Cell Carcinoma of the Bladder
IRB Number   CTSU C90601
Category   Genitourinary
Inclusion/Notes   T4b N2-N3 or M1, No prior treatment for metatstatic disease
Status   Active
Start Date   09/11/2009
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Medical Oncologist
Contact Name   Judy Miller RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.